Stockhub

Lumosa Therapeutics Co., Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 23:3523:35, 22 September 2022‎ 95.149.241.133 talk‎ 742 bytes +742‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Lumosa Therapeutics Co., Ltd., a clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan. The company offers LT - 1001, an analgesic injection that has completed Phase III clinical trials for severe pain relief after surgery. It is also developing LT3001, which is in Phase II clinical trial for the treatment of acute ischemic stroke; LT5001 that has complet..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Lumosa_Therapeutics_Co.,_Ltd.’